Varian Brings Machine Learning to Proton Treatment Planning with Eclipse v16

Driven by its Intelligent Cancer Care approach in developing new solutions that use advanced technologies like machine learning, Varian (NYSE: VAR), today announced the newest release of its treatment planning system, Eclipse v16.